Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Adrenocortical carcinoma
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Epidemiology == * Rare - one per million annual incidence * Almost always 40-50yo, but can occur in <5yo children == Risk factors == * Li-Fraumeni, MEN 1, Beckwith-Wiedemann syndrome == Pathophysiology == * Metastasises to liver and lungs commonly == Clinically == * Most cause signs and symptoms * Most patients present with stage III or IV disease - symptoms are often caused by the mets * May be associated with increased steroid hormone secretion with biochemical features of Cushing's syndrome == Diagnosis == * CT: irregular borders, higher attenuation values, heterogenous, central necrosis, invasion, possibly local lymphatic mets or distant disease * Tend to be very large at presentation (9-13cm mean size), and have usually spread beyond adrenal gland * Histopathological criteria: Weiss (reticulin alterations in the presence of at least one of necrosis, high mitotic rate, venous invasion) == Workup: == * FDG PET * CT CAP * Consider MRI to check for local invasion * Consider brain imaging (brain mets are rare, but do happen) * Exclude functional tumours especially phaeo (>50% of adrenocortical carcinoma are functional - most commonly Cushing, followed by virilisation) * Do not biopsy percutaneously if being considered for surgery == Treatment == * Resect stage I-III - radical ** Role for locoregional lymphadenectomy is unclear at this point, but resect all visible disease, including en bloc resection of adjacent organs ** Can be especially hard for large right-sided lesions due to direct extension into IVC or heart. Intravascular extension may require resection on ECMO to prevent embolisation. ** Open adrenalectomy is generally better for malignancy * Stage IV ** Chemotherapy - mitotane, a derivative of DDT that is a direct adrenocortical toxin ** Can be given as adjuvant therapy, which probably improves survival ** Radiotherapy can be considered, especially for R1 resections, palliative, or when there is a biopsy tract to be dealt with == Prognosis == * 40% 5-year survival among patients who undergo R0 resection ** Extremely limited survival for those who have incomplete resection (<1 year) ** Even if R0, local recurrence tends to occur within two years * Overall 5-year survival of 15-20% [[Category:Endocrine]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Adrenocortical carcinoma
Add topic